Expanding FIH Phase 1 Inpatient Wards for Reinforcing Early Phase Oncology Clinical ...

Expanding FIH Phase 1 inpatient wards for reinforcing early phase o...

View More

AbbVie ABBV-324 -First Administration of Investigational Cancer Drug in Asia (Global...

On July 8, 2025, the Department of New Experimental Therapeutics an...

View More

Boehringer Ingelheim BI770371’s NCT06806852 trial – the “First patient i...

On June 17, 2025, the Department of New Experimental Therapeutics a...

View More

Selected to be AbbVie’s Phase 1 Partnerships for Excellence in Research (P1PER) Glob...

Department of New Experimental Therapeutics, Early-Phase 1 Drug Dev...

View More